February 13, 2020
Foundation Medicine
Foundation Medicine and Chugai Announce Partnership with National Cancer Center for the Use of FoundationOne®Liquid in the Third Stage of SCRUM-Japan
February 12, 2020
Allena Pharmaceuticals
Allena Pharmaceuticals Announces Streamlined Design for URIROX-2, Second Pivotal Clinical Trial of Reloxaliase for Enteric Hyperoxaluria
February 12, 2020
KALA BIO
Kala Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results
February 12, 2020
Revolution Medicines
Revolution Medicines Announces Pricing of Initial Public Offering
February 06, 2020
Blueprint Medicines
Blueprint Medicines Announces PDUFA Date Extension for New Drug Application of Avapritinib for the Treatment of Adults with Fourth-Line Gastrointestinal Stromal Tumor